浓缩胰岛素在糖尿病管理中起什么作用？

What is the role of concentrated insulin in diabetes management?

作者信息

Mospan Cortney M

机构信息

Cortney M. Mospan is an assistant professor of pharmacy practice at East Tennessee State University's Bill Gatton College of Pharmacy in Johnson City, Tenn. She also serves as a clinical pharmacist with Mooney's Discount Pharmacy in Johnson City. The author has disclosed no potential conflicts of interest, financial or otherwise.

出版信息

JAAPA. 2016 Jun;29(6):16-8. doi: 10.1097/01.JAA.0000483103.42630.8b.

DOI:10.1097/01.JAA.0000483103.42630.8b

PMID:27228041

Abstract

Two concentrated analog insulins, long-acting insulin glargine U-300 (Toujeo) and rapid-acting insulin lispro (Humalog U-200), were recently approved by the FDA. Providers must be aware of clinical differences in these new product formulations compared with their nonconcentrated formulations, so that they can select appropriate patients for these products and minimize drug errors.

摘要

两种浓缩型类似物胰岛素，长效甘精胰岛素U-300（托优乐）和速效赖脯胰岛素（优泌乐U-200），最近获得了美国食品药品监督管理局（FDA）的批准。医疗服务提供者必须了解这些新产品剂型与非浓缩剂型相比的临床差异，以便他们能够为这些产品选择合适的患者，并尽量减少用药错误。